MacroGenics, Inc. (MGNX) Presents at Barclays 28th Annual Global Healthcare Conference Transcript [Seeking Alpha]
MacroGenics (MGNX) Reports Q4 Loss, Tops Revenue Estimates [Yahoo! Finance]
MacroGenics (MGNX) had its price target raised by Barclays PLC from $3.00 to $4.00. They now have an "overweight" rating on the stock.
MacroGenics Reports 2025 Financial Results and Highlights Upcoming Planned Data Disclosures [Yahoo! Finance]
MacroGenics Reports 2025 Financial Results and Highlights Upcoming Planned Data Disclosures